LCO No. 2098 1 of 1
General Assembly Proposed Bill No. 6224
January Session, 2021
LCO No. 2098
Referred to Committee on GENERAL LAW
Introduced by:
REP. RYAN, 139th Dist.
AN ACT PROMOTING DRUG PRICE TRANSPARENCY.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
That the general statutes be amended to require drug manufacturers 1
to report drug price increases in excess of ten per cent in a twelve-month 2
period or in excess of sixteen per cent in a twenty-four-month period, to 3
require manufacturers to report specified information regarding new 4
brand name and generic prescription drugs with prices above certain 5
thresholds, and to require manufacturers to report specific information 6
regarding newly acquired brand name drugs having retail prices over 7
one hundred dollars for a thirty-day supply or generic drugs having 8
retail prices over fifty dollars for a thirty-day supply. 9
Statement of Purpose:
To promote drug price transparency.